| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine, and concerns a method for identification of an agent for treating cancer and inflammatory diseases consisting in determining an ability of the agent to react with OG domain MMP-9 wherein said agent is a putative reductive regulator of collagenolytic activity MMP and determining an ability of said agent for reductive regulation of collagenolytic activity MMP-9. n EFFECT: invention provides reduction of collagenolytic activity MMP-9. n 10 cl, 7 ex, 7 dwg, 2 tbl |